Skip to content
Cryogenic Storage in Pharma: Preserving Drugs, Vaccines & Biologics

Cryogenic Storage in Pharma: Preserving Drugs, Vaccines & Biologics

In pharmaceutical and biotech research, the ability to store experimental drugs, vaccines, and biologics under cryogenic conditions is critical for ensuring their stability, efficacy, and safety. Cryogenic storage, which involves preserving biological materials at ultra-low temperatures (typically below -150°C), is essential for maintaining the structural and functional integrity of sensitive compounds. This article explores the significance of cryogenic storage in pharmaceutical and biotech research, the methods used, and best practices for ensuring optimal sample preservation.

Importance of Cryogenic Storage in Pharmaceutical and Biotech Research

1. Maintaining Drug Stability

Many experimental drugs, vaccines, and biologics contain proteins, nucleic acids, and other biomolecules that degrade over time due to temperature fluctuations, oxidation, or enzymatic activity. Cryogenic storage helps slow down these degradation processes, extending the shelf life of critical materials.

2. Ensuring Vaccine Viability

Vaccines, particularly those based on mRNA (such as COVID-19 vaccines), require ultra-low temperatures to remain effective. Without proper cryogenic storage, these vaccines lose their potency, making them ineffective in disease prevention.

3. Preserving Biologics for Long-Term Research

Biologics, including monoclonal antibodies, recombinant proteins, and gene therapy products, require consistent storage conditions to maintain their therapeutic properties. Cryopreservation ensures that biologics remain viable for long-term studies and regulatory approvals.

4. Regulatory Compliance

Pharmaceutical companies must comply with strict regulatory guidelines set by agencies such as the FDA and EMA, which mandate rigorous stability testing. Cryogenic storage ensures that experimental drugs and biologics maintain their quality throughout clinical trials and manufacturing processes.

Cryogenic Storage Methods

1. Liquid Nitrogen (LN2) Storage (-196°C to -150°C)

Liquid nitrogen is one of the most widely used cryogenic storage methods due to its ultra-low temperature capabilities. Samples are stored in:

  • Liquid phase (-196°C): Fully submerged in liquid nitrogen for maximum stability.

  • Vapor phase (-150°C to -190°C): Stored above liquid nitrogen to reduce the risk of contamination.

2. Ultra-Low Temperature (ULT) Freezers (-80°C to -150°C)

ULT freezers are commonly used for pharmaceutical research where slightly higher temperatures are sufficient. These freezers provide stable environments for:

  • Storing protein-based drugs.

  • Preserving cell cultures and bacterial strains.

  • Keeping vaccine candidates stable before large-scale production.

3. Dry Ice Storage (-78°C)

Dry ice is used for temporary cryogenic storage and transportation of experimental drugs and vaccines. While not ideal for long-term storage, it helps maintain sample integrity during transit.

Best Practices for Cryogenic Storage in Pharmaceutical and Biotech Research

1. Selecting the Right Cryogenic Vials

Cryogenic vials must be made from materials that can withstand extreme temperatures without cracking or degrading. Polypropylene vials with O-ring seals are commonly used to prevent contamination and leakage.

2. Proper Labeling and Inventory Management

  • Use barcode or RFID tagging for efficient sample tracking.

  • Maintain detailed records of sample origin, date of storage, and intended use.

  • Implement inventory management software to prevent sample mix-ups.

3. Controlled Rate Freezing for Sample Integrity

A controlled-rate freezer (CRF) ensures gradual cooling of biologic samples, preventing ice crystal formation, which can damage cellular structures. This is particularly important for:

  • Stem cells.

  • Cell-based drug candidates.

  • Genetically engineered tissue samples.

4. Ensuring Backup Power and Redundancy

To avoid catastrophic sample loss, laboratories should have:

  • Backup power generators to maintain freezer functionality during power outages.

  • Alarm systems that alert researchers in case of temperature fluctuations.

  • Duplicate storage locations to prevent complete loss of critical samples.

5. Compliance with Good Manufacturing Practices (GMP)

Cryogenic storage must follow GMP guidelines, which include:

  • Validating freezer performance and temperature monitoring systems.

  • Conducting regular maintenance and calibration of storage equipment.

  • Implementing stringent documentation practices for regulatory approvals.

Applications of Cryogenic Storage in Stability Testing

1. Accelerated Stability Testing

Cryogenic storage allows for long-term stability studies by freezing samples at ultra-low temperatures and periodically thawing them for analysis. This helps researchers determine:

  • The degradation rate of experimental drugs.

  • The impact of storage conditions on vaccine potency.

  • The long-term viability of biologics.

2. Freeze-Thaw Cycle Studies

Many pharmaceutical formulations undergo freeze-thaw cycles to test their resistance to temperature fluctuations. These studies are crucial for:

  • Assessing formulation robustness.

  • Understanding potential aggregation or denaturation of proteins.

  • Ensuring that drugs remain effective after multiple storage cycles.

3. Long-Term Biobank Storage

Pharmaceutical companies and research institutions maintain biobanks containing thousands of cryogenically stored samples. These biobanks support:

  • Retesting of experimental drug formulations.

  • Comparative studies for regulatory submissions.

  • Retrospective analyses of biologic drug stability.

4. Cell Line and Genetic Material Preservation

Cryogenic storage is essential for preserving cell lines used in biologic drug development. Key applications include:

  • Storage of genetically modified cell lines for monoclonal antibody production.

  • Cryopreservation of patient-derived cells for personalized medicine research.

  • Gene therapy vector stability testing under ultra-low temperatures.

Challenges in Cryogenic Storage and Solutions

1. Risk of Contamination

  • Use sealed cryogenic vials to prevent microbial contamination.

  • Store samples in the vapor phase of liquid nitrogen to minimize cross-contamination risks.

2. Temperature Fluctuations

  • Implement real-time temperature monitoring with automated alerts.

  • Maintain a backup nitrogen supply to replenish storage tanks in case of depletion.

3. Sample Retrieval Issues

  • Organize storage locations systematically to minimize sample handling.

  • Use inventory management software to track sample locations.

4. Cost of Cryogenic Storage

  • Optimize storage space by using high-density cryogenic racks.

  • Invest in energy-efficient ULT freezers to reduce operational costs.

Leave a comment

Your email address will not be published..

Cart 0

Your cart is currently empty.

Start Shopping